Metallothioneins, ageing and cellular senescence: A future therapeutic target

Current Pharmaceutical Design

Volumn 19, Issue 9, 2013, Pages 1753-1764

  Mocchegiani, Eugenio ^a   Costarelli, Laura ^a   Basso, Andrea ^a   Giacconi, Robertina ^a   Piacenza, Francesco ^a   Malavolta, Marco ^a  

^a INRCA   (Italy)

Author keywords

Ageing; Cellular senescence; Inflammation; Metallothioneins; MT target therapeutic approach

Indexed keywords

HOMOCYSTEINE; METALLOTHIONEIN;

AGING; APOPTOSIS; ARTICLE; CELL AGING; CELL SENESCENCE; HUMAN; MICROARRAY ANALYSIS; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; SENESCENCE;

EID: 84876735812     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161213805219595     Document Type: Article

References (175)

1. Kirkwood TB. Understanding the odd science of aging. Cell 2005; 120: 437-47.
2. Hayflick L. Biological aging is no longer an unsolved problem. Ann N Y Acad Sci 2007; 1100: 1-13.
3. Haigis MC, Yankner BA. The aging stress response. Mol Cell 2010; 40: 333-44.
4. Seviour EG, Lin SY. The DNA damage response: Balancing the scale between cancer and ageing. Aging (Albany NY) 2010; 2: 900-7.
5. Campisi J, Vijg J. Does damage to DNA and other macromolecules play a role in aging? If so, how? J Gerontol A Biol Sci Med Sci 2009; 64: 175-8.
6. Koga H, Kaushik S, Cuervo AM. Protein homeostasis and aging: The importance of exquisite quality control. Ageing Res Rev 2011; 10: 205-15.
7. Douglas PM, Dillin A. Protein homeostasis and aging in neurodegeneration. J Cell Biol 2010; 190: 719-29.
8. Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8: 729-40.
9. Vallee BL. The function of metallothionein. Neurochem Int 1995; 27: 23-33.
10. Mocchegiani E, Muzzioli M, Giacconi R. Zinc, metallothioneins, immune responses, survival and ageing. Biogerontology 2000; 1: 133-43.
11. Krezel A, Maret W. Dual nanomolar and picomolar Zn(II) binding properties of metallothionein. J Am Chem Soc 2007;129:10911-21.
12. Thornalley PJ, Vasák M. Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochim Biophys Acta 1985; 827: 36-44.
13. Maret W, Krezel A. Cellular zinc and redox buffering capacity of metallothionein/thionein in health and disease. Mol Med 2007; 13: 371-5.
14. West AK, Stallings R, Hildebrand CE, Chiu R, Karin M, Richards RI. Human metallothionein genes: structure of the functional locus at 16q13. Genomics 1990; 8: 513-8.
15. Krezel A, Maret W. Different redox states of metallothionein/ thionein in biological tissue. Biochem J 2007; 402: 551-8.
16. Sato M, Kondoh M. Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals. Tohoku J Exp Med 2002;196: 9-22.
17. Studer R, Vogt CP, Cavigelli M, Hunziker PE, Kägi JH. Metallothionein accretion in human hepatic cells is linked to cellular proliferation. Biochem J 1997; 328: 63-7.
18. Mocchegiani E, Muzzioli M, Giacconi R. Zinc and immunoresistance to infection in aging: new biological tools. Trends Pharmacol Sci 2000; 21: 205-8.
19. Wang Y, Wimmer U, Lichtlen P, et al. Metal-responsive transcription factor-1 (MTF-1) is essential for embryonic liver development and heavy metal detoxification in the adult liver. FASEB J 2004; 18: 1071-79.
20. Andrews GK, Lee DK, Ravindra R, et al. The transcription factors MTF-1 and USF1 cooperate to regulate mouse metallothionein-I expression in response to the essential metal zinc in visceral endoderm cells during early development. EMBO J 2001; 20: 1114-22.
21. Klaassen CD, Liu J, Diwan BA. Metallothionein protection of cadmium toxicity. Toxicol Appl Pharmacol 2009; 238: 215-20.
22. Bremner I, Davies NT. The induction of metallothionein in rat liver by zinc injection and restriction of food intake. Biochem J 1975; 149: 733-38.
23. Andrews GK. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem Pharmacol 2000; 59: 95-104.
24. Reinecke F, Levanets O, Olivier Y, et al. Metallothionein isoform 2A expression is inducible and protects against ROS-mediated cell death in rotenone-treated HeLa cells. Biochem J 2006; 395: 405-15.
25. Maret W. Metallothionein redox biology in the cytoprotective and cytotoxic functions of zinc. Exp Gerontol 2008; 43: 363-69.
26. Kröncke KD, Fehsel K, Schmidt T, et al. Nitric oxide destroys zinc-sulfur clusters inducing zinc release from metallothionein and inhibition of the zinc finger-type yeast transcription activator LAC9. Biochem Biophys Res Commun 1994; 200: 1105-10.
27. Chen Y, Irie Y, Keung WM, Maret W. S-nitrosothiols react preferentially with zinc thiolate clusters of metallothionein III through transnitrosation. Biochemistry 2002 41: 8360-7.
28. Maret W. Oxidative metal release from metallothionein via zincthiol/ disulfide interchange. Proc Natl Acad Sci USA 1994; 91: 237-41.
29. Jacob C, Maret W, Vallee BL. Selenium redox biochemistry of zinc-sulfur coordination sites in proteins and enzymes. Proc Natl Acad Sci USA 1999; 96: 1910-14.
30. Chen Y, Maret W. Catalytic oxidation of zinc/sulfur coordination sites in proteins by selenium compounds. Antioxid Redox Signal 2001; 3: 651-56.
31. Stoyanovsky DA, Tyurina YY, Tyurin VA, et al. Thioredoxin and lipoic acid catalyze the denitrosation of low molecular weight and protein S-nitrosothiols. J Am Chem Soc 2005; 127:15815-23.
32. Sagher D, Brunell D, Brot N, Vallee BL, Weissbach H. Selenocompounds can serve as oxidoreductants with the methionine sulfoxide reductase enzymes. J Biol Chem 2006; 281: 31184-87.
33. Ayaz M, Turan B. Selenium prevents diabetes-induced alterations in [Zn2+]i and metallothionein level of rat heart via restoration of cell redox cycle. Am J Physiol Heart Circ Physiol 2006; 290: H1071-80.
34. Maret W. Zinc coordination environments in proteins as redox sensors and signal transducers. Antioxid Redox Signal 2006; 8:1419-41.
35. Frederickson CJ, Maret W, Cuajungco MP. Zinc and excitotoxic brain injury: a new model. Neuroscientist 2004; 10: 18-25.
36. Bossy-Wetzel E, Talantova MV, Lee WD, et al. Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels. Neuron 2004; 41: 351-65.
37. Stork CJ, Li YV. Intracellular zinc elevation measured with a "calcium-specific" indicator during ischemia and reperfusion in rat hippocampus: a question on calcium overload. J Neurosci 2006; 26: 10430-37.
38. Carrasco J, Penkowa M, Giralt M, et al. Role of metallothionein-III following central nervous system damage. Neurobiol Dis 2003; 13: 22-36.
39. Togawa T, Sengupta S, Chen H, et al. Mechanisms for the formation of protein-bound homocysteine in human plasma. Biochem Biophys Res Commun 2000; 277: 668-74.
40. Barbato JC, Catanescu O, Murray K, DiBello PM, Jacobsen DW. Targeting of metallothionein by L-homocysteine: a novel mechanism for disruption of zinc and redox homeostasis. Arterioscler Thromb Vasc Biol 2007; 27: 49-54.
41. Colgan SM, Austin RC. Homocysteinylation of metallothionein impairs intracellular redox homeostasis: the enemy within! Arterioscler Thromb Vasc Biol 2007; 27: 8-11.
42. Futakawa N, Kondoh M, Ueda S, et al. Involvement of oxidative stress in the synthesis of metallothionein induced by mitochondrial inhibitors. Biol Pharm Bull 2006; 29: 2016-20.
43. Lindeque JZ, Levanets O, Louw R, van der Westhuizen FH. The involvement of metallothioneins in mitochondrial function and disease. Curr Protein Pept Sci 2010; 11: 292-309.
44. Wang GW, Klein JB, Kang YJ. Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes. J Pharmacol Exp Ther 2001; 298:461-68.
45. Aiuchi T, Mihara S, Nakaya M, Masuda Y, Nakajo S, Nakaya K. Zinc ions prevent processing of caspase-3 during apoptosis induced by geranylgeraniol in HL-60 cells. J Biochem 1998; 124: 300-3.
46. Mocchegiani E, Costarelli L, Giacconi R, Piacenza F, Basso A, Malavolta M. Zinc, metallothioneins and immunosenescence: ef fect of zinc supply as nutrigenomic approach. Biogerontology 2011; 12: 455-65.
47. Loh SN. The missing zinc: p53 misfolding and cancer. Metallomics 2010; 2: 442-49.
48. Kondo Y, Rusnak JM, Hoyt DG, Settineri CE, Pitt BR, Lazo JS. Enhanced apoptosis in metallothionein null cells. Mol Pharmacol 1997; 52: 195-201.
49. Fernández-Vizarra E, Enríquez JA, Pérez-Martos A, Montoya J, Fernández-Silva P. Tissue-specific differences in mitochondrial activity and biogenesis. Mitochondrion 2011; 11: 207-13.
50. Dzitoyeva S, Chen H, Manev H. Effect of aging on 5-hydroxymethylcytosine in brain mitochondria. Neurobiol Aging 2012 Mar 22. doi.org/10.1016/j.neurobiolaging.2012.02.006
51. Brouwer M, Hoexum-Brouwer T, Cashon RE. A putative glutathione-binding site in CdZn-metallothionein identified by equilibrium binding and molecular-modelling studies. Biochem J 1993; 294: 219-25.
52. Casadei M, Persichini T, Polticelli F, Musci G, Colasanti M. Sglutathionylation of metallothioneins by nitrosative/oxidative stress. Exp Gerontol 2008; 43: 415-22.
53. Maret W. Oxidative metal release from metallothionein via zincthiol/ disulfide interchange. Proc Natl Acad Sci U S A 1994;91:237-41.
54. Ye B, Maret W, Vallee BL. Zinc metallothionein imported into liver mitochondria modulates respiration. Proc Natl Acad Sci USA 2001; 98:2317-22.
55. Costello LC, Guan Z, Franklin RB, Feng P. Metallothionein can function as a chaperone for zinc uptake transport into prostate and liver mitochondria. J Inorg Biochem 2004; 98:664-66.
56. Feng W, Cai J, Pierce WM, et al. Metallothionein transfers zinc to mitochondrial aconitase through a direct interaction in mouse hearts. Biochem Biophys Res Commun 2005; 332: 853-58.
57. Singh KK, Desouki MM, Franklin RB, Costello LC. Mitochondrial aconitase and citrate metabolism in malignant and non-malignant human prostate tissues. Mol Cancer 2006; 5: 14-18.
58. Dineley KE, Richards LL, Votyakova TV, Reynolds IJ. Zinc causes loss of membrane potential and elevates reactive oxygen species in rat brain mitochondria. Mitochondrion 2005; 5: 55-65.
59. Kleiner D, von Jagow G. On the inhibition of mitochondrial electron transport by Zn(2+) ions. FEBS Lett 1972; 20: 229-32.
60. Maret W, Jacob C, Vallee BL, Fischer EH. Inhibitory sites in enzymes: zinc removal and reactivation by thionein. Proc Natl Acad Sci USA 1999; 96: 1936-40.
61. Jacob C, Maret W, Vallee BL. Control of zinc transfer between thionein, metallothionein, and zinc proteins. Proc Natl Acad Sci USA 1998; 95: 3489-94.
62. Wyss M, Smeitink J, Wevers RA, Wallimann T. Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism. Biochim Biophys Acta 1992; 1102:119-66.
63. Chen Z, Li J, Zhao TJ, et al. Metallothioneins protect cytosolic creatine kinases against stress induced by nitrogen-based oxidants. Biochem J 2012; 441: 623-32.
64. Miura N, Koizumi S. Gene expression profiles in the liver and kidney of metallothionein-null mice. Biochem Biophys Res Commun 2005; 332: 949-55.
65. Kenyon C. The first long-lived mutants: discovery of the insulin/ IGF-1 pathway for ageing. Philos Trans R Soc Lond B Biol Sci 2011; 366: 9-16.
66. Penkowa M, Cáceres M, Borup R, et al. Novel roles for metallothionein-I + II (MT-I + II) in defense responses, neurogenesis, and tissue restoration after traumatic brain injury: insights from global gene expression profiling in wild-type and MT-I + II knockout mice. J Neurosci Res 2006; 84:1452-74.
67. Selman C, Tullet JM, Wieser D, et al. Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 2009; 326: 140-44.
68. Kelly EJ, Quaife CJ, Froelick GJ, Palmiter RD. Metallothionein I and II protect against zinc deficiency and zinc toxicity in mice. J Nutr 1996; 126:1782-90.
69. Michalska AE, Choo KH. Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. Proc Natl Acad Sci USA 1993; 90: 8088-92.
70. Beattie JH, Wood AM, Newman AM, et al. Obesity and hyperleptinemia in metallothionein (-I and-II) null mice. Proc Natl Acad Sci USA 1998; 95: 358-63.
71. Cherian MG, Kang YJ. Metallothionein and liver cell regeneration. Exp Biol Med (Maywood) 2006; 231: 138-44.
72. Inoue K, Takano H, Kaewamatawong T, et al. Role of metallothionein in lung inflammation induced by ozone exposure in mice. Free Radic Biol Med 2008; 45:1714-22.
73. Leung YK, Pankhurst M, Dunlop SA, et al. Metallothionein induces a regenerative reactive astrocyte phenotype via JAK/STAT and RhoA signalling pathways. Exp Neurol 2010; 221: 98-106.
74. Malavolta M, Cipriano C, Costarelli L, et al. Metallothionein downregulation in very old age: a phenomenon associated with cellular senescence? Rejuvenation Res 2008; 11: 455-59.
75. Mocchegiani E, Costarelli L, Giacconi R, Cipriano C, Muti E, Malavolta M. Zinc-binding proteins (metallothionein and alpha-2 macroglobulin) and immunosenescence. Exp Gerontol 2006; 41:1094-1107.
76. de Magalhães JP, Budovsky A, Lehmann G, Costa J, Li Y, Fraifeld V, Church GM. The Human Ageing Genomic Resources: online databases and tools for biogerontologists. Aging Cell 2009; 8:65-72.
77. Bruunsgaard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. Curr Opin Hematol 2001; 8: 131-36.
78. de Magalhães JP, Toussaint O. GenAge: a genomic and proteomic network map of human ageing. FEBS Lett 2004; 571: 243-47.
79. Muffat J, Walker DW, Benzer S. Human ApoD, an apolipoprotein up-regulated in neurodegenerative diseases, extends lifespan and increases stress resistance in Drosophila. Proc Natl Acad Sci USA 2008; 105:7088-93.
80. Siritantikorn A, Johansson K, Ahlen K, et al. Protection of cells from oxidative stress by microsomal glutathione transferase 1. Biochem Biophys Res Commun 2007; 355: 592-96.
81. Malavolta M, Basso A, Piacenza F, et al. Survival study of Metallothionein-1 transgenic mice and respective controls (C57BL/6J): influence of a zinc-enriched environment. Rejuvenation Res 2012; 15:140-43.
82. Yang X, Doser TA, Fang CX, et al. Metallothionein prolongs survival and antagonizes senescence-associated cardiomyocyte diastolic dysfunction: role of oxidative stress. FASEB J 2006; 20:1024-26.
83. Schriner SE, Linford NJ, Martin GM, et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 2005; 308: 1909-11.
84. Swindell WR. Accelerated failure time models provide a useful statistical framework for aging research. Exp Gerontol 2009; 44: 190-200.
85. Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science 2009; 324: 98-102.
86. Eckschlager T, Adam V, Hrabeta J, Figova K, Kizek R. Metallothioneins and cancer. Curr Protein Pept Sci 2009; 10: 360-75.
87. Mocchegiani E, Costarelli L, Giacconi R, et al. Nutrient-gene interaction in ageing and successful ageing. A single nutrient (zinc) and some target genes related to inflammatory/immune response. Mech Ageing Dev 2006; 127: 517-25.
88. Feng W, Benz FW, Cai J, Pierce WM, Kang YJ. Metallothionein disulfides are present in metallothionein-overexpressing transgenic mouse heart and increase under conditions of oxidative stress. J Biol Chem 2006; 281: 681-87.
89. Maret W. Redox biochemistry of mammalian metallothioneins J Biol Inorg Chem 2011; 16:1079-1086
90. Zangger K, Oz G, Haslinger E, Kunert O, Armitage IM. Nitric oxide selectively releases metals from the amino-terminal domain of metallothioneins: potential role at inflammatory sites. FASEB J 2001; 15: 1303-05.
91. Spahl DU, Berendji-Grün D, Suschek CV, Kolb-Bachofen V, Kröncke KD. Regulation of zinc homeostasis by inducible NO synthase-derived NO: nuclear metallothionein translocation and intranuclear Zn2+ release. Proc Natl Acad Sci USA 2003; 100:13952-57.
92. Williams PD, Day T. Antagonistic pleiotropy, mortality source interactions, and the evolutionary theory of senescence. Evolution 2003; 57:1478-88.
93. Swindell WR. Heat shock proteins in long-lived worms and mice with insulin/insulin-like signaling mutations. Aging (Albany NY) 2009; 1: 573-77.
94. Vanhooren V, Liu XE, Desmyter L, et al. Over-expression of heat shock protein 70 in mice is associated with growth retardation, tu mor formation, and early death. Rejuvenation Res 2008; 11: 1013-20.
95. Adams PC, Reboussin DM, Press RD, et al. Biological variability of transferrin saturation and unsaturated iron-binding capacity. Am J Med 2007; 120: 999. e1-7.
96. Lio D, Balistreri CR, Colonna-Romano G, et al. Association between the MHC class I gene HFE polymorphisms and longevity: a study in Sicilian population. Genes Immun 2002; 3: 20-4.
97. Mocchegiani E, Malavolta M, Costarelli L, et al. Zinc, metallothioneins and immunosenescence. Proc Nutr Soc 2010; 69: 290-99.
98. Moroni F, Di Paolo ML, Rigo A, et al. Interrelationship among neutrophil efficiency, inflammation, antioxidant activity and zinc pool in very old age. Biogerontology 2005; 6: 271-81.
99. Bahadorani S, Mukai S, Egli D, Hilliker AJ. Overexpression of metal-responsive transcription factor (MTF-1) in Drosophila melanogaster ameliorates life-span reductions associated with oxidative stress and metal toxicity. Neurobiol Aging 2010; 31:1215-26.
100. Swindell WR. Gene expression profiling of long-lived dwarf mice: longevity associated genes and relationships with diet, gender and aging. BMC Genomics 2007; 8: 353-58.
101. Barsyte D, Lovejoy DA, Lithgow GJ. Longevity and heavy metal resistance in daf-2 and age-1 long-lived mutants of Caenorhabditis elegans. FASEB J 2001; 15: 627-34.
102. Mocchegiani E, Santarelli L, Costarelli L, et al. Plasticity of neuroendocrine-thymus interactions during ontogeny and ageing: role of zinc and arginine. Ageing Res Rev 2006; 5: 281-309.
103. Paolisso G, Ammendola S, Del Buono A, et al. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentration, insulin action and cognitive function. J Clin Endocrinol Metab 1997; 82: 2204-09.
104. Bonafè M, Barbieri M, Marchegiani F, et al. Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control. J Clin Endocrinol Metab 2003; 88: 3299-304.
105. Wilson M, Hogstrand C, Maret W. Picomolar concentrations of free zinc(II) ions regulate receptor protein-tyrosine phosphatase β activity. J Biol Chem 2012; 287: 9322-6.
106. Chen JX, Tuo Q, Liao DF, Zeng H. Inhibition of protein tyrosine phosphatase improves angiogenesis via enhancing Ang-1/Tie-2 signaling in diabetes. Exp Diabetes Res 2012; 2012: 836759-63.
107. Cipriano C, Malavolta M, Costarelli L, et al. Polymorphisms in MT1a gene coding region are associated with longevity in Italian Central female population. Biogerontology 2006; 7: 357-65.
108. Giacconi R, Cipriano C, Muti E, et al. Novel-209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc. Biogerontology 2005; 6: 407-13.
109. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965; 37: 614-36.
110. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005; 120: 513-22.
111. Emsley JG, Mitchell BD, Kempermann G, Macklis JD. Adult neurogenesis and repair of the adult CNS with neural progenitors, precursors, and stem cells. Prog Neurobiol 2005; 75: 321-41.
112. Espinosa JM, Verdun RE, Emerson BM. p53 functions through stress-and promoter-specific recruitment of transcription initiation components before and after DNA damage. Mol Cell 2003; 12: 1015-27.
113. Vilborg A, Wilhelm MT, Wiman KG. Regulation of tumor suppressor p53 at the RNA level. J Mol Med (Berl) 2010; 88: 645-52.
114. Rainwater R, Parks D, Anderson ME, Tegtmeyer P, Mann K. Role of cysteine residues in regulation of p53 function. Mol Cell Biol 1995; 15: 3892-903.
115. Méplan C, Richard MJ, Hainaut P. Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells. Oncogene 2000; 19:5227-36.
116. Verhaegh GW, Parat MO, Richard MJ, Hainaut P. Modulation of p53 protein conformation and DNA-binding activity by intracellular chelation of zinc. Mol Carcinog 1998; 21:205-14.
117. Toussaint O, Weemaels G, Debacq-Chainiaux F, Scharffetter-Kochanek K, Wlaschek M. Artefactual effects of oxygen on cell culture models of cellular senescence and stem cell biology. J Cell Physiol 2011; 226: 315-21.
118. Liu L, Blasco M, Trimarchi J, Keefe D. An essential role for functional telomeres in mouse germ cells during fertilization and early development. Dev Biol 2002; 249:74-84.
119. Zwerschke W, Mazurek S, Stöckl P, Hütter E, Eigenbrodt E, Jansen-Dürr P. Metabolic analysis of senescent human fibroblasts reveals a role for AMP in cellular senescence. Biochem J 2003; 376: 403-11.
120. Chomyn A, Attardi G. MtDNA mutations in aging and apoptosis. Biochem Biophys Res Commun 2003; 304:519-29.
121. Passos JF, von Zglinicki T. Mitochondria, telomeres and cell senescence. Exp Gerontol 2005; 40: 466-72.
122. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345: 458-60.
123. Puca R, Nardinocchi L, Bossi G, et al. Restoring wtp53 activity in HIPK2 depleted MCF7 cells by modulating metallothionein and zinc. Exp Cell Res 2009; 315: 67-75.
124. Jeyapalan JC, Ferreira M, Sedivy JM, Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev. 2007; 128: 36-44.
125. Cipriano C, Tesei S, Malavolta M, et al. Accumulation of cells with short telomeres is associated with impaired zinc homeostasis and inflammation in old hypertensive participants. J Gerontol A Biol Sci Med Sci 2009; 64:745-51.
126. Yang HY, Wang YM, Peng SQ. Metallothionein-I/II null cardiomyocytes are sensitive to Fusarium mycotoxin butenolide-induced cytotoxicity and oxidative DNA damage. Toxicon 2010; 55:1291-96.
127. Namdarghanbari M, Wobig W, Krezoski S, Tabatabai NM, Petering DH. Mammalian metallothionein in toxicology, cancer, and cancer chemotherapy. J Biol Inorg Chem 2011; 16: 1087-101.
128. Campisi J. The biology of replicative senescence. Eur J Cancer 1997; 33: 703-09.
129. Chen Z, Trotman LC, Shaffer D, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005; 436: 725-30.
130. Cipriano C, Giacconi R, Muzzioli M, et al. Metallothionein (I+II) confers, via c-myc, immune plasticity in oldest mice: model of partial hepatectomy/liver regeneration. Mech Ageing Dev 2003; 124: 877-86.
131. Kren BT, Trembley JH, Steer CJ. Alterations in mRNA stability during rat liver regeneration. Am J Physiol 1996; 270: G763-77.
132. Freund A, Orjalo AV, Desprez PY, Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med 2010; 16: 238-46.
133. Allavena P, Garlanda C, Borrello MG, Sica A, Mantovani A. Pathways connecting inflammation and cancer. Curr Opin Genet Dev 2008; 18: 3-10.
134. Campisi J, Andersen JK, Kapahi P, Melov S. Cellular senescence: a link between cancer and age-related degenerative disease? Semin Cancer Biol 2011; 21:354-59.
135. Kortlever RM, Higgins PJ, Bernards R. Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat Cell Biol 2006; 8:877-84.
136. Acosta JC, O'Loghlen A, Banito A, Raguz S, Gil J. Control of senescence by CXCR2 and its ligands. Cell Cycle 2008; 7:2956-59.
137. Kuilman T, Michaloglou C, Vredeveld LC, et al. Oncogeneinduced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008; 133: 1019-31.
138. Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 2004; 6: 447-58.
139. Ancrile B, Lim KH, Counter CM. Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes Dev 2007; 21:1714-19.
140. Rutsch S, Neppalli VT, Shin DM, et al. IL-6 and MYC collaborate in plasma cell tumor formation in mice. Blood 2010; 115:1746-54.
141. Mocchegiani E, Giacconi R, Cipriano C, et al. MtmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker of immunosenescence: lessons from very old mice and humans. Exp Gerontol 2002; 37: 349-57.
142. Millis AJ, Hoyle M, McCue HM, Martini H. Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. Exp Cell Res 1992; 201: 373-79.
143. Kojima I, Tanaka T, Inagi R, et al. Metallothionein is upregulated by hypoxia and stabilizes hypoxia-inducible factor in the kidney. Kidney Int 2009; 75: 268-77.
144. Li Q, Ren J. Cardiac overexpression of metallothionein attenuates chronic alcohol intake-induced cardiomyocyte contractile dysfunction. Cardiovasc Toxicol 2006; 6: 173-82.
145. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006; 124: 471-84.
146. Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004; 18:1926-45.
147. Demidenko ZN, Blagosklonny MV. Growth stimulation leads to cellular senescence when the cell cycle is blocked. Cell Cycle 2008; 7:3355-61.
148. Feng Z, Zhang H, Levine AJ, Jin S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 2005; 102: 8204-09.
149. McCormick MA, Tsai SY, Kennedy BK. TOR and ageing: a complex pathway for a complex process. Philos Trans R Soc Lond B Biol Sci 2011; 366: 17-27.
150. Maret W. The function of zinc metallothionein: a link between cellular zinc and redox state. J Nutr 2000; 130: 1455S-1458S.
151. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003; 426: 194-98.
152. Herbig U, Jobling WA, Chen BP, Chen DJ, Sedivy JM. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell 2004; 14: 501-13.
153. Xue W, Zender L, Miething C, et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445: 656-60.
154. Chang E, Harley CB. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 1995; 92: 11190-94.
155. Kwong J, Hong L, Liao R, Deng Q, Han J, Sun P. p38alpha and p38gamma mediate oncogenic ras-induced senescence through differential mechanisms. J Biol Chem 2009; 284: 11237-46.
156. Mocchegiani E, Costarelli L, Giacconi R, Piacenza F, Basso A, Malavolta M. Micronutrient (Zn, Cu, Fe)-gene interactions in ageing and inflammatory age-related diseases: implications for treatments. Ageing Res Rev 2012; 11: 297-319.
157. Zhu X, Liu Q, Wang M, et al. Activation of Sirt1 by resveratrol inhibits TNF-β induced inflammation in fibroblasts. PLoS One 2011; 6: e27081.
158. Mahlknecht U, Zschoernig B. Involvement of sirtuins in life-span and aging related diseases. Adv Exp Med Biol 2012; 739: 252-61.
159. Chen L, Feng Y, Zhou Y, et al. Dual role of Zn2+ in maintaining structural integrity and suppressing deacetylase activity of SIRT1. J Inorg Biochem 2010; 104:180-85.
160. Ota H, Akishita M, Eto M, Iijima K, Kaneki M, Ouchi Y. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J Mol Cell Cardiol 2007; 43: 571-79.
161. Evans DS, Kapahi P, Hsueh WC, Kockel L. TOR signaling never gets old: aging, longevity and TORC1 activity. Ageing Res Rev 2011; 10: 225-37.
162. Bauer R. Metallothionein: a new soldier in the fight against chronic renal hypoxia? Kidney Int 2009; 75: 257-59.
163. Swindell WR. Dietary restriction in rats and mice: a meta-analysis and review of the evidence for genotype-dependent effects on lifespan. Ageing Res Rev 2012; 11: 254-70.
164. Sitzmann BD, Mattison JA, Ingram DK, Roth GS, Ottinger MA, Urbanski HF. Impact of moderate calorie restriction on the reproductive neuroendocrine axis of male rhesus macaques. Open Longev Sci 2010; 3: 38-47.
165. Ace CI, Okulicz WC. Microarray profiling of progesteroneregulated endometrial genes during the rhesus monkey secretory phase. Reprod Biol Endocrinol 2004; 2: 54-58.
166. Williamson DA, Martin CK, Anton SD, et al. Pennington CALERIE Team. Is caloric restriction associated with development of eating-disorder symptoms? Results from the CALERIE trial. Health Psychol 2008; 27: S32-42.
167. Huffman KM, Redman LM, Landerman LR, et al. Caloric restriction alters the metabolic response to a mixed-meal: results from a randomized, controlled trial. PLoS One 2012; 7: e28190.
168. Racette SB, Das SK, Bhapkar M, et al. CALERIE Study Group. Approaches for quantifying energy intake and % calorie restriction during calorie restriction interventions in humans: the multicenter CALERIE study. Am J Physiol Endocrinol Metab 2012; 302: E441-8.
169. Stein PK, Soare A, Meyer TE, Cangemi R, Holloszy JO, Fontana L. Caloric Restriction may reverse age-related autonomic decline in humans. Aging Cell 2012 Apr 17. doi: 10.1111/j.1474-9726.2012.00825.x.
170. Dunn MF, Pattison SE, Storm MC, Quiel E. Comparison of the zinc binding domains in the 7S nerve growth factor and the zincinsulin hexamer. Biochemistry 1980: 19: 718-25.
171. Haase H, Maret W. Fluctuations of cellular, available zinc modulate insulin signaling via inhibition of protein tyrosine phosphatases. J Trace Elem Med Biol 2005; 19: 37-42.
172. Tarapore P, Shu Y, Guo P, Ho SM. Application of phi29 motor pRNA for targeted therapeutic delivery of siRNA silencing metallothionein-IIA and survivin in ovarian cancers. Mol Ther 2011; 19: 386-94.
173. Yamasaki M, Nomura T, Sato F, Mimata H. Metallothionein is upregulated under hypoxia and promotes the survival of human prostate cancer cells. Oncol Rep 2007; 18: 1145-53.
174. Mocchegiani E; Zincage Consortium. Zinc, metallothioneins, longevity: effect of zinc supplementation on antioxidant response: a Zincage study. Rejuvenation Res 2008; 11:419-23.
175. Margalit O, Simon AJ, Yakubov E, et al. Zinc supplementation augments in vivo antitumor effect of chemotherapy by restoring p53 function. Int J Cancer 2011 Sep 19. doi: 10.1002/ijc.26441.